joae tirzepatide lawsuit LATEST UPDATE! compounding! Lawsuit! FDA Overreach? Mounjaro maker Eli Lilly takes

The second FDA-approved indication is for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, dyslipidemia, or obstructive sleep apnea

Ozempic (semaglutide), Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4 mg) are not just medical treatments, they are cultural currency

Tips: inject at night, eat smaller meals, and avoid fatty or heavily processed foods around injection day

Side Effects The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients